Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of morbidity and mortality worldwide
and is a frequent cause of skin and soft tissue infections (SSTIs). Lymphedema—fluid accumulation in tissue caused by
impaired lymphatic vessel function—is a strong risk factor for SSTIs. SSTIs also frequently recur in patients and
sometimes lead to acquired lymphedema. However, the mechanism of how SSTIs can be both the consequence and cause of lymphatic
vessel dysfunction is not known. Intravital imaging in mice revealed both an acute reduction in lymphatic vessel contractility and
lymph flow after localized MRSA infection. Moreover, chronic lymphatic impairment is observed long after MRSA is cleared and
inflammation is resolved. Associated with decreased collecting lymphatic vessel function was the loss and disorganization of
lymphatic muscle cells (LMCs), which are critical for lymphatic contraction. In vitro, incubation of
MRSA-conditioned supernatant led to LMC death. Proteomic analysis identified several accessory gene regulator
(agr)-controlled MRSA exotoxins that contribute to LMC death. Infection with agr mutant MRSA
resulted in sustained lymphatic function compared to animals infected with wild type MRSA. Our findings suggest that
agr is a promising target to preserve lymphatic vessel function and promote immunity during SSTIs.